Peripheral inflammation, concomitant with obesity and diabetes, is directly related to AD, demonstrated by higher plasma and central nervous system (CNS) levels of IL-6, IL-1β and TNF-α in patients with AD.1 Animal models have demonstrated that systemic inflammation may lead to central inflammation due to microglial activation. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.